Inhibition of cytochrome P450 enzymes participating in p-nitrophenol hydroxylation by drugs known as CYP2E1 inhibitors.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Chemico-Biological Interactions

• Publication date

  2004-04-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.CBI.2004.03.003PMID 15135088
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of cytochromes P450 by antifungal imidazole derivatives.

  2002cited by this paper
• Reduction of toxic metabolite formation of acetaminophen.

  2002cited by this paper
• Paracetamol (Acetaminophen)-Induced Toxicity: Molecular and Biochemical Mechanisms, Analogues and Protective Approaches

  2001cited by this paper
• Substrate selectivity and metabolism

  2001cited by this paper
• Assessment of specificity of eight chemical inhibitors using cDNA-expressed cytochromes P450

  2000cited by this paper
• Effects of the Antifungal Agents on Oxidative Drug Metabolism

  2000cited by this paper
• Diclofenac and its derivatives as tools for studying human cytochromes P450 active sites: particular efficiency and regioselectivity of P450 2Cs.

  1999cited by this paper
• Molecular genetics of the human cytochrome P450 monooxygenase superfamily.

  1998cited by this paper
• Catalytic assays for human cytochrome P450.

  1998cited by this paper
• Oxidation of acetaminophen to its toxic quinone imine and nontoxic catechol metabolites by baculovirus-expressed and purified human cytochromes P450 2E1 and 2A6.

  1998cited by this paper
• Inhibition of human hepatic cytochrome P4502E1 by azole antifungals, CNS-active drugs and non-steroidal anti-inflammatory agents.

  1998cited by this paper
• Both cytochromes P450 2E1 and 3A are involved in the O-hydroxylation of p-nitrophenol, a catalytic activity known to be specific for P450 2E1.

  1997cited by this paper
• Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes.

  1996cited by this paper
• Role of cytochrome P450 in DNA damage induced by N-nitrosodialkylamines in cultured rat hepatocytes.

  1996cited by this paper
• Use of tolbutamide as a substrate probe for human hepatic cytochrome P450 2C9.

  1996cited by this paper
• Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture

  1992cited by this paper
• Oxidative and reductive metabolism by cytochrome P450 2E1

  1992cited by this paper
• Separation of human liver microsomal tolbutamide hydroxylase and (S)-mephenytoin 4'-hydroxylase cytochrome P-450 enzymes.

  1991cited by this paper
• Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1.

  1991cited by this paper
• Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1

  1990cited by this paper
• Cytochrome P450IIE1: roles in nitrosamine metabolism and mechanisms of regulation.

  1990cited by this paper
• The utility of p-nitrophenol hydroxylation in P450IIE1 analysis.

  1989cited by this paper
• Immunochemical and catalytical studies on hepatic coumarin 7-hydroxylase in man, rat, and mouse.

  1988cited by this paper
• Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism.

  1986cited by this paper
• Inhibition of rat liver microsomal cytochrome P-450 steroid hydroxylase reactions by imidazole antimycotic agents.

  1986cited by this paper
• p-Nitrophenol hydroxylation. A microsomal oxidation which is highly inducible by ethanol.

  1985cited by this paper
• Preparation and Properties of Partially Purified Cytochrome P-450 and Reduced Nicotinamide Adenine Dinucleotide Phosphate-Cytochrome P-450 Reductase from Rabbit Liver Microsomes

  1974cited by this paper
• Preparation and properties of partially purified cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductase from rabbit liver microsomes.

  1974cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Evaluation of pharmacokinetics and metabolism of three marine-derived piericidins for guiding drug lead selection.

  2025cites this paper
• The Impact of Dietary Interventions on the Pharmacokinetics of Antifungal Drugs: A Systematic Review with Meta-analyses

  2025cites this paper
• Nitrophenols disrupt the expression and activity of biotransformation enzymes (CYP3A and COMT) in chicken ovarian follicles in vivo and in vitro

  2024cites this paper
• Precision Medicine in Antidepressants Treatment.

  2023cites this paper
• Intestinal epithelial damage due to herbal compounds – an in vitro study

  2022influential citation
• Implications for herbal polypharmacy: coumarin-induced hepatotoxicity increased through common herbal phytochemicals astragaloside IV and atractylenolide I

  2022cites this paper
• Prospective Prediction of Dapaconazole Clinical Drug–Drug Interactions Using an In Vitro to In Vivo Extrapolation Equation and PBPK Modeling

  2022cites this paper
• Interplay between two degenerate spin state determines the hydroxylation of 4-nitrophenol catalyzed via Cytochrome P450

  2021cites this paper
• In vitro inhibitory effect of obtusofolin on the activity of CYP3A4, 2C9, and 2E1

  2021cites this paper
• A sensitive HPLC-FL method to simultaneously determine febuxostat and diclofenac in rat plasma: assessment of metabolic drug interactions in vitro and in vivo

  2020cites this paper
• Weight of evidence and human relevance evaluation of the benfluralin mode of action in rodents (part I): Liver carcinogenesis.

  2020cites this paper
• Weight of evidence and human relevance evaluation of the benfluralin mode of action in rodents (Part I): Liver carcinogenesis.

  2020cites this paper
• Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis

  2020cites this paper
• A comprehensive review of cytochrome P450 2E1 for xenobiotic metabolism

  2019cites this paper
• Deactivation of 12(S)-HETE through (ω-1)-hydroxylation and β-oxidation in alternatively activated macrophages[S]

  2018cites this paper
• Development of a non-mammalian, pre-clinical screening tool for the predictive analysis of drug toxicity

  2018cites this paper
• Effects of iloperidone, combined with desipramine, on alcohol drinking in the Syrian golden hamster.

  2016cites this paper
• Desipramine enhances the ability of paliperidone to decrease alcohol drinking.

  2015cites this paper
• Sterol metabolism controls T(H)17 differentiation by generating endogenous RORγ agonists.

  2015influential citation
• Para-nitrophenol hydroxylation by fish liver microsomes: kinetics and effect of selective cytochrome P450 inhibitors

  2011cites this paper
• Alleviation of cisplatin-induced acute kidney injury using phytochemical polyphenols is accompanied by reduced accumulation of indoxyl sulfate in rats

  2011cites this paper
• Can peroxygenase and microperoxidase substitute cytochrome P450 in biosensors

  2011cites this paper
• Nifedipine Lowers Cocaine-Induced Brain and Liver Enzyme Activity and Cocaine Urinary Excretion in Rats

  2011cites this paper
• The regulation of NOX4 expression by insulin and its role in the modulation of TGF-ß-induced apoptosis in murine hepatocytes

  2011cites this paper
• Drug-drug interactions by azole antifungals: Beyond a dogma of CYP3A4 enzyme activity inhibition.

  2011cites this paper
• bamazepine but Not Valproate Induces CYP 2 A 6 Activity in B & P okers with Mental Illness

  2010cites this paper
• Effect of cytisine on some brain and hepatic biochemical parameters in spontaneously hypertensive rats

  2010cites this paper
• Carbamazepine but Not Valproate Induces CYP2A6 Activity in Smokers with Mental Illness

  2010influential citation
• Bioelectrocatalytic properties of Agrocybe aegerita peroxygenase

  2010cites this paper
• Alterations in hepatic enzyme activity and progesterone clearance in lactating dairy cows

  2010cites this paper
• Malaria downmodulates mRNA expression and catalytic activities of CYP1A2, 2E1 and 3A11 in mouse liver.

  2009influential citation
• Estudos da cinética do antimônio e alterações de ci tocromos P450 hepáticos em primatas e ratos tratados com antimoniato de meglumina

  2008cites this paper
• Effect of sodium ozagrel on the activity of rat CYP2D6.

  2007cites this paper
• The role of intracellular signaling in insulin-mediated regulation of drug metabolizing enzyme gene and protein expression.

  2007cites this paper
• In Vitro Metabolism of the Fungicide and Environmental Contaminant trans-bromuconazole and Implications for Risk Assessment

  2007cites this paper
• Is bupropion a more specific substrate for porcine CYP2E than chlorzoxazone and p-nitrophenol?

  2007cites this paper
• Structure-functional characterization of cytochrome P4502E1 (CYP2E1)

  2007cites this paper
• The use of a fluorescence-based oxygen uptake assay in the analysis of cytotoxicity.

  2006cites this paper
• "Non-Antibiotics": alternative therapy for the management of MDRTB and MRSA in economically disadvantaged countries.

  2006cites this paper
• Drug-induced changes in P450 enzyme expression at the gene expression level: A new dimension to the analysis of drug–drug interactions

  2006cites this paper
• MINIPIG CYTOCHROME P450 2E1: COMPARISON WITH HUMAN ENZYME

  2005cites this paper
• Effect of antifungal drugs on cytochrome P450 (CYP) 2C9, CYP2C19, and CYP3A4 activities in human liver microsomes.

  2005cites this paper
• Effect of antifungal drugs on cytochrome P450 (CYP) 1A2, CYP2D6, and CYP2E1 activities in human liver microsomes.

  2005cites this paper
• COMPARISON WITH HUMAN ENZYME

  2005cites this paper